Patents by Inventor Stuart T. Nichol

Stuart T. Nichol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6620913
    Abstract: The present invention relates to the discovery of a novel Hantavirus. In particular, the present invention relates to nucleic acids of the newly discovered virus and to nucleic acid reagents and antibodies for use in methods of detection and prevention of infection by the virus.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: September 16, 2003
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Stuart T. Nichol, Christina F. Spiropoulou, Thomas G. Ksiazek, Pierre E. Rollin
  • Patent number: 5945277
    Abstract: The present invention relates to the discovery of a novel Hantavirus. In particular, the present invention relates to nucleic acids of the newly discovered virus and to nucleic acid reagents and antibodies for use in methods of detection and prevention of infection by the virus.
    Type: Grant
    Filed: May 30, 1996
    Date of Patent: August 31, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Stuart T. Nichol, Christina F. Spiropoulou, Thomas G. Ksiazek, Pierre E. Rollin
  • Patent number: 5916754
    Abstract: The present invention relates to the discovery and isolation of a novel hantavirus designated the Bayou hantavirus. In particular, the present invention relates to nucleic acids of the newly discovered virus and to nucleic acid reagents (primers and probes), purified polypeptides and antibodies for use in methods of detection and prevention of infection by the virus. A vaccine or purified immunogenic polypeptide of the Bayou hantavirus in a pharmaceutically acceptable carrier is provided. A vector comprising the nucleic acids of the invention is provided. A method of detecting the presence of a hantavirus in a subject comprising contacting an antibody-containing sample from the subject with a purified polypeptide of the invention and detecting the reaction of the polypeptide and the antibody is provided.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: June 29, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Stuart T. Nichol, Sergey Morzunov, Thomas G. Ksiazek, Pierre E. Rollin, Christina F. Spiropoulou
  • Patent number: 5853980
    Abstract: The present invention relates to the discovery and isolation of a novel hantavirus designated the Black Creek Canal hantavirus. In particular, the present invention relates to nucleic acids of the newly discovered virus and to nucleic acid reagents (primers and probes), purified polypeptides and antibodies for use in methods of detection and prevention of infection by the virus. A vaccine or purified immunogenic polypeptide of the Black Creek Canal hantavirus in a pharmaceutically acceptable carrier is provided. A vector comprising the nucleic acids of the invention is provided. A method of detecting the presence of a hantavirus in a subject comprising contacting an antibody-containing sample from the subject with a purified polypeptide of the invention and detecting the reaction of the polypeptide and the antibody is provided.
    Type: Grant
    Filed: February 3, 1997
    Date of Patent: December 29, 1998
    Assignees: The United States of America as represented by the Department of Health and Human Services, National Institutes of Health Office of Technology Transfer
    Inventors: Pierre E. Rollin, Luanne Elliott, Thomas G. Ksiazek, Stuart T. Nichol, Sergey Morzunov, Eugeny Ravkov